Post by jeffs on Jan 6, 2006 22:14:43 GMT -5
A randomized crossover study of bee sting therapy for multiple sclerosis
T. Wesselius, MD*, D. J. Heersema, MD, PhD*, J. P. Mostert, MD, M. Heerings, NP, F. Admiraal-Behloul, PhD, A. Talebian, MD, M. A. van Buchem, MD, PhD and J. De Keyser, MD, PhD
www.neurology.org/cgi/content/abstract/65/11/1764
Background: Bee sting therapy is increasingly used to treat patients with multiple sclerosis (MS) in the belief that it can stabilize or ameliorate the disease. However, there are no clinical studies to justify its use.
Results: During bee sting therapy, there was no significant reduction in the cumulative number of new gadolinium-enhancing lesions. The T2*-weighted lesion load further progressed, and there was no significant reduction in relapse rate. There was no improvement of disability, fatigue, and quality of life. Bee sting therapy was well tolerated, and there were no serious adverse events.
For the complete article: www.neurology.org/cgi/content/abstract/65/11/1764
T. Wesselius, MD*, D. J. Heersema, MD, PhD*, J. P. Mostert, MD, M. Heerings, NP, F. Admiraal-Behloul, PhD, A. Talebian, MD, M. A. van Buchem, MD, PhD and J. De Keyser, MD, PhD
www.neurology.org/cgi/content/abstract/65/11/1764
Background: Bee sting therapy is increasingly used to treat patients with multiple sclerosis (MS) in the belief that it can stabilize or ameliorate the disease. However, there are no clinical studies to justify its use.
Results: During bee sting therapy, there was no significant reduction in the cumulative number of new gadolinium-enhancing lesions. The T2*-weighted lesion load further progressed, and there was no significant reduction in relapse rate. There was no improvement of disability, fatigue, and quality of life. Bee sting therapy was well tolerated, and there were no serious adverse events.
For the complete article: www.neurology.org/cgi/content/abstract/65/11/1764